434 related articles for article (PubMed ID: 27429196)
1. LncRNAs in pancreatic cancer.
Huang X; Zhi X; Gao Y; Ta N; Jiang H; Zheng J
Oncotarget; 2016 Aug; 7(35):57379-57390. PubMed ID: 27429196
[TBL] [Abstract][Full Text] [Related]
2. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer.
Peng W; Jiang A
Biomed Pharmacother; 2016 Oct; 83():712-717. PubMed ID: 27470572
[TBL] [Abstract][Full Text] [Related]
4. The regulatory roles of long noncoding RNAs in the biological behavior of pancreatic cancer.
Li Y; Yang X; Kang X; Liu S
Saudi J Gastroenterol; 2019; 25(3):145-151. PubMed ID: 30720003
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma.
Huang JL; Zheng L; Hu YW; Wang Q
Carcinogenesis; 2014 Mar; 35(3):507-14. PubMed ID: 24296588
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma.
Chen B; Zhang Q; Wang X; Wang Y; Cui J; Zhuang H; Tang J
Aging (Albany NY); 2020 Feb; 12(4):3647-3661. PubMed ID: 32090981
[TBL] [Abstract][Full Text] [Related]
7. Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review.
Al-Noshokaty TM; Mansour A; Abdelhamid R; Abdellatif N; Alaaeldien A; Reda T; Abdelmaksoud NM; Doghish AS; Abulsoud AI; Elshaer SS
Pathol Res Pract; 2023 May; 245():154438. PubMed ID: 37043965
[TBL] [Abstract][Full Text] [Related]
8. Long Non-coding RNA LINC01420 Contributes to Pancreatic Cancer Progression Through Targeting KRAS Proto-oncogene.
Zhai H; Zhang X; Sun X; Zhang D; Ma S
Dig Dis Sci; 2020 Apr; 65(4):1042-1052. PubMed ID: 31562613
[TBL] [Abstract][Full Text] [Related]
9. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion.
Liu S; Zhang J; Yin L; Wang X; Zheng Y; Zhang Y; Gu J; Yang L; Yang J; Zheng P; Jiang Y; Shuai L; Cai X; Wang H
Cell Death Dis; 2020 Jun; 11(6):412. PubMed ID: 32487998
[TBL] [Abstract][Full Text] [Related]
10. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway.
Zhan HX; Wang Y; Li C; Xu JW; Zhou B; Zhu JK; Han HF; Wang L; Wang YS; Hu SY
Cancer Lett; 2016 May; 374(2):261-71. PubMed ID: 26898939
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer.
Chen P; Wan D; Zheng D; Zheng Q; Wu F; Zhi Q
Biomed Pharmacother; 2016 Oct; 83():1220-1226. PubMed ID: 27562722
[TBL] [Abstract][Full Text] [Related]
12. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p.
Huang B; Liu C; Wu Q; Zhang J; Min Q; Sheng T; Wang X; Zou Y
Biochem Biophys Res Commun; 2017 Jan; 482(4):828-834. PubMed ID: 27888106
[TBL] [Abstract][Full Text] [Related]
15. AB209630, a long non-coding RNA decreased expression in hypopharyngeal squamous cell carcinoma, influences proliferation, invasion, metastasis, and survival.
Zhou J; Li M; Yu W; Li W; Wang J; Xiang X; Li G; Pan X; Lei D
Oncotarget; 2016 Mar; 7(12):14628-38. PubMed ID: 26895099
[TBL] [Abstract][Full Text] [Related]
16. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
Hu P; Shangguan J; Zhang L
Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers.
Wang Y; Li Z; Zheng S; Zhou Y; Zhao L; Ye H; Zhao X; Gao W; Fu Z; Zhou Q; Liu Y; Chen R
Oncotarget; 2015 Nov; 6(34):35684-98. PubMed ID: 26447755
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of key microRNAs in pancreatic cancer development.
Baradaran B; Shahbazi R; Khordadmehr M
Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]